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KEY POINTS SUMMARY  
 Hypoxia, a potent activator of the sympathetic nervous system, is known to
increase muscle sympathetic nerve activity (MSNA) to the peripheral 
vasculature of native Lowlanders during sustained high altitude (HA) 
exposure. 
 We show that the arterial baroreflex control of MSNA functions normally in
healthy Lowlanders at HA, and that upward baroreflex resetting permits 
chronic activation of basal sympathetic vasomotor activity under this 
condition. 
 The baroreflex MSNA operating point and resting sympathetic vasomotor
outflow both are lower for highland Sherpa compared with acclimatizing 
Lowlanders; these lower levels may represent beneficial hypoxic adaptation in 
Sherpa. 
 Acute hyperoxia at HA had minimal effect on baroreflex control of MSNA in
Lowlanders and Sherpa, raising the possibility that mechanisms other than 
peripheral chemoreflex activation contribute to vascular sympathetic 
baroreflex resetting and sympathoexcitation. 
 These findings provide better understanding of sympathetic nervous system
activation and control of blood pressure during the physiological stress of 
sustained HA hypoxia. 
ABSTRACT 
Exposure to high altitude (HA) is characterized by heightened muscle sympathetic 
neural activity (MSNA); however, the effect on arterial baroreflex control of MSNA is 
unknown. Furthermore, arterial baroreflex control at HA may be influenced by 
genotypic and phenotypic differences between lowland and highland natives. 
Fourteen Lowlanders (10 male) and 9 male Sherpa underwent haemodynamic and 
sympathetic neural assessment at low altitude (Lowlanders, LA; 344m, Sherpa, KT; 
1400m) and following gradual ascent to 5050m. Beat-by-beat haemodynamics 
(photoplethysmography) and MSNA (microneurography) were recorded lying supine. 
Indices of vascular sympathetic baroreflex function were determined from the 
relationship of diastolic blood pressure (DBP) and corresponding MSNA at rest (i.e. 
DBP „operating pressure‟ and MSNA „operating point‟), and during a modified Oxford 
baroreflex test (i.e. „gain‟). Operating pressure and gain were unchanged for 
Lowlanders during HA exposure; however, the operating point was reset upwards 
(48 ± 16 vs 22 ± 12 bursts·100HB-1, P=0.001). Compared to Lowlanders at 5050m, 
Sherpa had similar gain and operating pressure, but operating point was lower (30 ± 
13 bursts·100HB-1P=0.02); MSNA burst frequency was lower for Sherpa (22 ± 11 
versus 30 ± 9 bursts·min-1 P = 0.03). Breathing 100% oxygen did not alter vascular 
sympathetic baroreflex function for either group at HA. For Lowlanders, upward 
baroreflex resetting promotes heightened sympathetic vasoconstrictor activity and 
maintains blood pressure stability, at least during early HA exposure; mechanisms 
other than peripheral chemoreflex activation could be involved.  Sherpa adaptation 
appears to favour lower sympathetic vasoconstrictor activity than Lowlanders for 
blood pressure homeostasis. 
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INTRODUCTION 
The sympathetic nervous system is the ubiquitous controller of the cardiovascular 
system in humans, and thus plays a pivotal role in arterial pressure homeostasis 
(Guyenet, 2006). High altitude (HA) hypoxia is a major physiological stressor that is 
accompanied by a profound activation of muscle sympathetic nerve activity (MSNA), 
which is markedly greater than that observed during acute exposure to a similar 
hypoxic stimulus (Duplain et al., 1999; Lundby et al., 2017). Notably, 
sympathoexcitation is maintained for the duration of HA exposure, despite 
normalisation of resting arterial oxygen content to near sea-level values (Hansen & 
Sander, 2003; Lundby et al., 2017). Furthermore, sympathetic activation is not 
reversed whilst breathing 100% oxygen, and persists for up to 3 days following 
descent to low altitude (Hansen & Sander, 2003; Mitchell et al., 2018). These data 
suggest a form of neural “remodelling” associated with prolonged hypoxia. 
 Several studies have characterised MSNA and arterial pressure responses to 
sustained HA exposure in healthy Lowlanders (Hansen & Sander, 2003; Lundby et 
al., 2017; Fisher et al., 2018). Despite a greater probability of a burst of sympathetic 
vasoconstrictor activity at rest (i.e. 50% as opposed to 25%), any accompanying 
change in arterial pressure is relatively modest, at least for exposures lasting to 10-
50 days. These observations imply chronic resetting of the neural vasoconstrictor 
reflexes which attempt to maintain blood pressure, presumably to balance local 
vasodilator mechanisms and secure haemodynamic stability. However, the arterial 
baroreflex control of sympathetic vasoconstrictor activity has never been investigated 
at HA. 
Relatively little is known regarding the consequences of lifelong HA hypoxia 
on sympathetic activity and blood pressure regulation.  A single microneurographic 
study found similar basal MSNA, but lower arterial pressure, for Bolivian highlanders 
compared to well-acclimatised Lowlanders (Lundby et al., 2017); arterial baroreflex 
function was not tested. This suggests sustained sympathetic activation may be an 
evolutionary adaptation for those living permanently under HA hypoxia. However, 
distinct differences in physiological adaptation are known to exist between natives of 
the South American Andes, Himalaya plateau and Ethiopian highlands (Beall, 2006, 
2007; Erzurum et al., 2007), with the suggestion that the Sherpa (Himalayan) 
adaptation represents the most effective phenotype for chronic hypoxia (Gilbert-
Kawai et al., 2014; Horscroft et al., 2017). However, due to a lack of 
microneurographic data for highlanders, other than Bolivians, it is unclear whether 
differences in the patterns of adaptation extends to sympathetic nervous system 
control of the cardiovascular system and arterial pressure homeostasis. 
Therefore, the aims of this study were (1) to examine baroreflex regulation 
(resetting and gain) in healthy Lowlanders at 5050m, following 10 to 20 days of 
acclimatization and, (2) to compare arterial baroreflex function between acclimatizing 
Lowlanders and HA native Sherpa. Based upon previous reports for acute hypoxia  
(Halliwill & Minson, 2002; Halliwill et al., 2003; Steinback et al., 2009; Querido et al., 
2011), we hypothesized that the „operating pressure‟ (i.e. diastolic blood pressure) 
and „operating point‟ (i.e. MSNA burst incidence) of the vascular sympathetic 
baroreflex would shift to higher values, during HA acclimatisation, with no change in 
reflex „gain‟ (i.e. slope). We further hypothesized that Sherpa, who cope extremely 
well with chronic hypoxia, would have lower arterial pressure and lower MSNA 
operating point, compared with Lowlanders. 
METHODS 
Ethical Approval 
All testing procedures had Institutional Review Board approval from the University of 
British Colombia (H16-01297/H16-01028), University of Alberta, and Nepal Health 
Research Council. All participants were informed, using the native language, of the 
purpose and the risks involved with each procedure, and provided oral and written 
informed consent, in compliance with the latest revision of the Declaration of 
Helsinki, except for registration in a database. 
Participants 
Fourteen Lowlanders (twelve male; mean ± SD: age, 27 ± 6 yrs; height, 1.77 ± 0.8 
m; weight, 72.2 ± 10.1 kg) and nine male Sherpa (age, 33 ± 12 yrs; height, 1.68 ± 
0.07 m; weight, 65.3 ± 10.3 kg) participated. All Sherpa were natives of the Khumbu 
valley (> 3440 metres). None of the participants had any history or symptoms of 
cardiovascular, respiratory, metabolic and neurological disease, and were not taking 
any prescription or over-the-counter medication during the time of participation. Five 
Sherpa were self-reported smokers (1-5 cigarettes per day). None of the Lowlanders 
experienced clinical acute mountain sickness (AMS) at the time of testing, as 
assessed by the Lake Louise questionnaire (LLQ score ≤3); however, one was 
tested 2 days following an intramuscular injection of dexamethasone (half-life, 3 
hours).  All participants abstained from caffeine and vigorous exercise for 12 hours 
prior to all testing session and arrived at the laboratory a minimum of 2 hours after a 
light meal. 
Experimental design 
This experiment was carried out within the framework of the 2016 UBC Nepal 
Expedition to the Ev-K2-CNR Research Facility (Willie et al., 2018). Participants for 
the present study were also recruited for a number of other investigations. Therefore, 
care was taken to ensure that no overlap existed between any of the studies, and the 
present study addressed its own distinct a priori research question. Data collected 
during the testing sessions described in the following paragraph, but with separate a 
priori analyses, are presented elsewhere (Busch et al., 2017). 
All participants underwent two testing sessions. Pre-expedition, low altitude 
(LA), testing of Lowlanders was conducted at 344m (Kelowna, Canada, barometric 
pressure, 758 ± 8mmHg). Pre-expedition testing of Sherpa was conducted at 1400m 
(Kathmandu [KT], Nepal; barometric pressure, 652 ± 3mmHg); this was performed a 
minimum of 4 days following descent from their resident altitude. All of the HA testing 
was performed at 5050 m (barometric pressure, 431 ± 44mmHg). These tests 
followed a gradual trek (i.e. 9 or 10 days), starting at 2860m with rest days at both 
3400m and 4240m. Sherpa were studied on days 1-4 at 5050m (i.e. 10-14 days 
above 2860m), and Lowlanders were studied on days 1-10 (i.e. 10-20 days). 
Measurements 
Haemodynamics 
Heart rate (HR) and beat-by-beat blood pressure (BP) were continuously recorded 
using Lead II electrocardiogram and finger photoplethysmography (Finometer Pro, 
Finapres Medical Systems BV, Amsterdam, Netherlands). Mean arterial pressure 
(MAP), and systolic (SBP) and diastolic (DBP) blood pressures, were calculated from 
the arterial pressure waveform, which was calibrated against manual brachial artery 
pressure measurements. Cardiac output (CO) was estimated using the Model Flow 
algorithm and used to estimate total peripheral resistance (TPR = MAP/CO). 
Peripheral capillary oxygen saturation (SpO2) was determined using finger pulse 
oximetry (Nellcor, Medtronics, USA). 
Muscle sympathetic nerve activity 
Multi-unit MSNA was recorded from the peroneal (common fibular) nerve via 
microneurography (JPM/CDS) as previously described (Steinback & Shoemaker, 
2012; Usselman et al., 2015). MSNA signal was confirmed by pulse-synchronous 
activity that responded to end-expiratory apnea but not to startle stimuli or skin 
stroking (Delius et al., 1972a, 1972b). Nerve signals were amplified (1000x pre-
amplifier and 100x variable gain isolated amplifier), band pass filtered (700-2,000Hz) 
rectified (model 662C-3; Iowa University Bioengineering; USA) and integrated (decay 
constant 0.1s). 
Experimental protocol 
Basal sympathetic neural activity 
Following arrival at the laboratory, subjects rested in the supine position and an 
antecubital venous cannula was inserted for subsequent drug administration. 
Following instrumentation, acquisition of an acceptable MSNA signal and a period of 
stabilisation, 10 minutes of baseline data were recorded. 
Arterial baroreflex function 
Vascular sympathetic and cardiovagal baroreflex function was determined from the 
MSNA and R-R Interval (RRI) responses during arterial pressure perturbations 
induced by a single modified Oxford baroreflex test (Rudas et al., 1999) during 
ambient air breathing. Briefly, the modified Oxford test involved bolus injection of 
sodium nitroprusside (SNP), followed 90 seconds later by phenylephrine (PE). Prior 
to experimental testing, bolus doses of SNP and PE that evoked ~15mmHg 
perturbations above and below resting BP were determined for each individual. The 
same relative dose (µg·kg-1) was administered at LA and HA for a given individual. 
Doses of vasoactive drugs administered and resultant blood pressure changes are 
shown in Table 1. 
Arterial baroreflex-peripheral chemoreflex interaction 
At LA, a modified Oxford test was also performed whilst breathing a gas mixture 
containing 11% oxygen (equivalent to 5050m), to increase peripheral chemoreceptor 
drive (acute hypoxia, AH). At both LA and HA, a single modified Oxford test was also 
performed whilst participants breathed 100% oxygen (LA + 100% O2, HA + 100% 
O2), to acutely eliminate peripheral chemoreceptor drive. Participants breathed each 
of the gas mixtures for a minimum of 5 minutes; as soon as a new steady state SpO2 
was achieved, the modified Oxford test was performed. No attempt was made to 
control ventilation or end tidal CO2 during manipulation of peripheral chemoreceptor 
drive. At least 20 minutes separated the modified Oxford tests. The order of trials at 
LA were not randomized as persistent alterations in MSNA and vascular sympathetic 
baroreflex function have been shown following acute hypoxia stimulus (Querido et 
al., 2011). 
Data analyses 
All haemodynamic data were sampled at 1KHz using a commercial data acquisition 
software (LabChart Pro v 8.3.1, AD Instruments, Sydney, Australia) and stored for 
offline analysis. The raw MSNA signal was sampled at 10 KHz. Multi-unit bursts of 
MSNA were identified using a semi-automated detection algorithm (Chart Pro 8.3.1) 
and confirmed by a trained observer (SAB/CDS). To account for vascular 
sympathetic baroreflex latency, MSNA data were shifted backwards (Average; 1.32 ± 
0.07s) so that the peak of each sympathetic burst coincided with the diastolic period 
that initiated it (Usselman et al., 2015). Burst amplitude data were normalised by 
assigning a value of 100 to the largest burst observed during baseline and calibrating 
all other bursts against this value. Resting MSNA was quantified as burst frequency 
(burst·min-1), burst incidence (burst·100HB-1), mean burst amplitude (a.u) and total 
activity (mean burst amplitude x burst frequency [au·min-1]).  
Vascular sympathetic baroreflex gain was estimated from the relationship 
between DBP and MSNA burst probability during a modified Oxford test. DBP was 
used because MSNA correlates more closely with DBP than SBP (Sundlof & Wallin, 
1978). All DBP values were assigned to a 3 mmHg bin to reduce the statistical 
impact of respiratory related oscillations (Eckberg & Eckberg, 1982). The percentage 
of cardiac cycles associated with a burst of MSNA (ranging from 0-100%) was 
calculated for each DBP bin to give values of burst probability (Usselman et al., 
2015). Non-linear saturation and threshold regions, if present, were excluded 
through visual inspection of data points by agreement of two observers (LLS/JPM). 
The slope of the linear relationship was determined by weighted linear regression 
analysis, and this value provided an index of vascular sympathetic baroreflex gain. 
Only slopes with (i) at least five data points and (ii) R≥ 0.5 were included in the group 
mean data (Hart et al., 2011; Taylor et al., 2015). Vascular sympathetic baroreflex 
gain for rising and falling pressures were not determined independently. The 
vascular sympathetic baroreflex operating point was taken as the average values for 
DBP and MSNA burst incidence during the resting period immediately prior to the 
modified Oxford test. 
Cardiovagal baroreflex gain was estimated from the relationship between SBP 
and RRI during each modified Oxford test. SBP was used as it correlates more 
closely with RRI than DBP (Sundlof & Wallin, 1978). Values were averaged over 
3mmHg SBP bins. Baroreflex delays were accounted for by associating SBP values 
with either the concurrent heartbeat (when resting RRI >800msec) or subsequent 
heartbeat (when resting RRI <800msec) (Eckberg & Eckberg, 1982). Saturation and 
threshold regions were excluded through visual inspection of data (LLS/JPM). 
Slopes were determined by weighted linear regression analysis and only slopes with 
at least five data points and R ≥ 0.8 were included in the group mean data. To 
minimize the potential effects of hysteresis, we restricted data analysis to the rising 
arm of SBP during the modified Oxford test (Hunt & Farquhar, 2005). The 
cardiovagal baroreflex operating point was taken as the average value for SBP and 
RRI during the resting period immediately prior to the modified Oxford test. 
Statistical analyses 
The effects of HA acclimatization in Lowlanders were assessed using paired t-tests, 
whereas differences between Lowlanders and Sherpa at HA and Sherpa at HA and 
Lowlanders at LA were assessed using independent t-tests. The effects of 
manipulating peripheral chemoreceptor drive on baroreflex function at LA (AH, LA + 
100% O2) and HA (HA + 100% O2) were assessed using paired t-tests. Multiple t-
tests were chosen to maximize the number of subjects included in statistical 
analyses. A priori alpha was adjusted, using the experiment-wise error rate, to 
correct for multiple comparisons (Busch et al., 2017). All statistical analyses were 
performed using Prism 7.03 (GraphPad software, USA) and statistical significance 
was set at P<0.05 a priori. Group data are reported as means (± SD). 
RESULTS 
Resting haemodynamics, basal sympathetic neural activity, and arterial 
baroreflex function 
Examples of MSNA and haemodynamic data recorded in one Lowlander and one 
Sherpa, under each of the experimental conditions, are presented in Figure 1. In 
Lowlanders (n=14), SpO2 was decreased and HR was increased with HA 
acclimatization, whereas CO, TPR, and MAP were similar compared to LA. All 
parameters of MSNA were greater in Lowlanders at HA compared to LA (Table 2). 
Due to technically challenging conditions during pre-expedition testing at KT, 
resting sympathetic neural activity could only be obtained in 4 out of 9 Sherpa, and 1 
of these 4 Sherpa was not re-tested at HA (Table 2). At HA, Sherpa (n=8) and 
Lowlanders had a similar SpO2 and resting haemodynamics; however, Sherpa 
exhibited significantly lower MSNA burst frequency than Lowlanders, with no 
difference in mean burst amplitude. Compared to Lowlanders at LA, Sherpa had 
lower SpO2 and higher HR, but similar CO, TPR and MAP. Sherpa exhibited 
significantly greater MSNA burst frequency, and mean burst amplitude, versus 
Lowlanders at LA. 
Data from ten Lowlanders were included in the comparisons of sympathetic 
and cardiovagal baroreflex function, as baroreflex slopes for four participants did not 
fulfil the inclusion criteria. HA acclimatization had no effect on the baroreflex diastolic 
operating pressure for Lowlanders, but the MSNA operating point (burst incidence) 
was increased compared to LA. Vascular sympathetic baroreflex gain (i.e. slope) 
was not different at LA and HA (Figure 2). HA acclimatization resulted in a downward 
shift of the cardiovagal baroreflex, reflected by a reduction in RRI, with no change in 
prevailing SBP; this was accompanied by a reduction in reflex gain (Figure 3). 
Modified Oxford tests were performed successfully in 7 out of 8 Sherpa 
investigated at HA; no baroreceptor tests were performed in KT. At HA, the diastolic 
operating pressure for Sherpa was similar to that of Lowlanders, but the MSNA 
operating point was lower for Sherpa. There was no difference in vascular 
sympathetic baroreflex gain (Figure 2). Furthermore, when compared to Lowlanders 
at LA, operating pressure, operating point and vascular sympathetic baroreflex gain 
for Sherpa were similar. The cardiovagal baroreflex gain in Sherpa was similar to 
that for Lowlanders at HA, but less than that of Lowlanders at LA. The cardiovagal 
baroreflex operating SBP was similar for Sherpa, compared to Lowlanders at both 
HA and LA, whereas RRI was similar to Lowlanders at HA, but lower than that at LA 
(Figure 3). In Sherpa, cardiovagal baroreflex gain was similar to that of Lowlanders 
at HA, but less than that of Lowlanders at LA. 
Arterial baroreflex-peripheral chemoreflex interaction at low altitude 
Due to the loss of MSNA signals in three participants, the data analyses for arterial 
baroreflex-peripheral chemoreflex interactions at LA are for eleven Lowlanders 
(Table 3). AH reduced SpO2, increased HR, MAP and CO, and decreased TPR. 
MSNA burst frequency was unchanged, but total MSNA was increased, due to an 
augmented burst amplitude. Vascular sympathetic baroreflex gain was reduced 
during AH, with no change in baroreflex diastolic operating pressure, or the MSNA 
operating point. Administration of 100% oxygen at LA had no effect on baseline 
haemodynamics, MSNA burst frequency, burst amplitude, or indices of vascular 
sympathetic and cardiovagal baroreflex function. 
Arterial baroreflex-peripheral chemoreflex interaction at high altitude 
As a result of MSNA signal losses, these comparisons were performed for nine 
Lowlanders and four Sherpa (Table 4). For Lowlanders exposed to 100% O2, SpO2 
and MAP increased, and HR decreased, with no effect on any other baseline 
haemodynamics or MSNA. Vascular sympathetic baroreflex function gain was also 
unchanged. There was no change in cardiovagal baroreflex gain. For Sherpa 
breathing 100% oxygen, SpO2 increased and HR decreased with no effect on other 
baseline haemodynamics. MSNA burst frequency, burst incidence, total activity and 
total MSNA were unchanged; however, mean burst amplitude decreased. Vascular 
sympathetic baroreflex gain was unchanged. Breathing 100% oxygen reduced RRI, 
with no change in cardiovagal baroreflex gain. 
DISCUSSION 
Principal novel findings are as follows: (1) Baroreflex control of MSNA is preserved in 
Lowlanders following 10-20 days at HA; (2) The operating point of the vascular 
sympathetic baroreflex is upwardly reset with no change in operating DBP for 
Lowlanders at HA; (3) Sherpa have lower basal MSNA burst frequency compared to 
Lowlanders at HA, but similar resting blood pressure; (4) Sherpa have similar 
vascular sympathetic baroreflex gain, but a lower operating point when compared 
with Lowlanders at HA. Finally, (5) eliminating peripheral chemoreceptor drive at HA 
did not influence the vascular sympathetic baroreflex operating point or gain for both 
Lowlanders and Sherpa. Taken together, these findings provide important new 
insight into reflex control of the vasoconstrictor drive and blood pressure at HA, and 
highlight a novel adaptation in Sherpa. 
Sympathoexcitation at high altitude 
Following 10-20 days of HA exposure, we observed an almost three-fold 
increase in MSNA burst frequency for Lowlanders at 5050m; this is consistent with 
previous microneurographic studies at HA (Hansen & Sander, 2003; Lundby et al., 
2017). Furthermore, for the first time, we demonstrate that the basal MSNA burst 
frequency of Sherpa is lower than that of Lowlanders at this altitude, despite similar 
peripheral oxygen saturation in both groups. Our observation for Sherpa contrasts 
with that of the only previous study of highlanders (Lundby et al., 2017), which found 
that Bolivian Aymara had basal MSNA that was comparable with Lowlanders after 10 
and 50 days of HA exposure. Although many factors may influence basal 
sympathetic outflow, the present study raises the importance of ethnicity. The 
divergent pathways of physiological adaptation observed in geographically distinct 
HA populations might extend to sympathetic nervous system activation, whereby 
adaptation in Sherpa appears to favour lower basal sympathetic activity. However, 
we also found that basal MSNA for Sherpa at HA was higher than that for 
Lowlanders at LA. Furthermore, for three Sherpa studied 4 days following descent to 
1440m, basal MSNA burst frequencies were approximately 30% lower than those 
observed when they were re-tested at 5050m.Taken together these findings suggest 
that hypoxia remains a significant physiological stressor for Sherpa despite 
generations of adaptation and lifelong exposure. 
Remarkably, resting MAP for Lowlanders was similar at LA and HA, despite 
the significantly elevated basal MSNA at 5050m. Moreover, Sherpa and Lowlanders 
exhibited similar MAP at 5050m, even though Sherpa had markedly less basal 
MSNA. This may reflect differences in the release of vasoactive substances and 
vascular sensitivity to these factors. It is possible that α adrenergic receptor 
sensitivity is reduced in Lowlanders during prolonged HA hypoxia, meaning that they 
require more MSNA to produce the same vascular response. That the same dose of 
phenylephrine administered during the modified Oxford test elicited a smaller pressor 
response for lowlanders at HA than at LA, supports this notion. Furthermore, Sherpa 
may possess a greater vascular responsiveness to sympathetic vasoconstrictor 
drive, meaning that the vascular effect of a burst of neural activity is greater. 
However, characterisation of a dose-response relationship to vasoactive substances 
would be required to confirm these possibilities. 
Arterial baroreflex function at high altitude 
Our data indicate an upward resetting of the vascular sympathetic baroreflex 
in Lowlanders at 5050m. This occurred without a change in the ability of the reflex to 
increase or decrease MSNA in response to a baroreceptor challenge i.e. the gain 
was unchanged.  Furthermore, the ability of the baroreflex to regulate MSNA in 
Sherpa and Lowlanders is similar, but the likelihood of a burst of MSNA at a given 
diastolic pressure is lower for Sherpa. Vascular sympathetic baroreflex function at 
HA had not been assessed prior to this study. Previous reports of heightened MSNA 
burst incidence (Hansen & Sander, 2003; Lundby et al., 2017; Fisher et al., 2018) 
indirectly support an upward resetting of the vascular sympathetic baroreflex 
operating point for Lowlanders exposed to chronic HA hypoxia. However, in contrast 
to this study, previous studies found an increase in resting MAP accompanied higher 
MSNA burst incidence (Hansen & Sander, 2003; Lundby et al., 2017; Fisher et al., 
2018). This may be due to methodological differences across studies in relation to 
the ascent profile, physical activity levels whilst at altitude, and the final elevation 
achieved. In addition, a temporal relationship may exist between elevated 
sympathetic vasomotor activity and MAP in Lowlanders. Arterial baroreflex resetting 
and heightened sympathetic outflow initially may be homeostatic during early 
acclimatisation; however, over time other cardiovascular changes and alterations in 
constricting and dilating factors acting on the vasculature (Calbet et al., 2014; Bruno 
et al., 2016) could contribute to elevated MAP at HA. We suggest that future studies 
at HA should incorporate serial measurements of arterial baroreflex control of MSNA 
and other factors that modulate arterial pressure. 
The secondary effects of increased ventilation at HA may complicate the 
effects of hypoxia on baroreflex control of the heart (Angell James & De Burgh Daly, 
1969; Eckberg et al., 1980). Nevertheless, we determined how the cardiovagal 
component of the arterial baroreflex was affected in this study. At HA, cardiovagal 
baroreflex gain was similar for Lowlanders and Sherpa, but we observed that the 
gain for Lowlanders was reduced compared with at LA. Interestingly, acute 
hyperoxia at 5050m did not reverse this reduction in gain for Lowlanders. Taken 
together, our data suggest that altitude acclimatization has differential effects on the 
responsiveness of the vascular sympathetic and cardiovagal limbs of the arterial 
baroreflex. 
Vascular sympathetic baroreflex-peripheral chemoreflex interactions 
For Lowlanders exposed to AH, there was no change in basal MSNA burst 
frequency, although there was a modest increase in mean burst amplitude and thus 
a modest increase in total activity. This implies that MSNA burst frequency and 
amplitude can be regulated independently of each other, as previously suggested 
(Kienbaum et al., 2001; Salmanpour et al., 2011; Steinback & Shoemaker, 2012). 
Furthermore, the operating point of the vascular sympathetic baroreflex was not 
significantly different during AH, while the gain was reduced. These findings for AH 
contrast with those for HA, and suggest different mechanisms contribute to activation 
of central sympathetic outflow during acute and chronic hypoxic exposure. Vascular 
sympathetic baroreflex resetting in Lowlanders at 5050m was not reversed during 
acute administration of 100% oxygen. Furthermore, MSNA burst frequency was not 
reduced, a finding that is consistent with previous studies that attempted to reduce 
peripheral chemoreflex drive at HA (Hansen & Sander, 2003; Fisher et al., 2018). 
Therefore, mechanisms other than the peripheral chemoreflex likely play a role in 
vascular sympathetic baroreflex resetting at HA. Interestingly, the peripheral 
chemoreflex may be more important in mediating HA sympathoexcitation in Sherpa. 
Although the vascular sympathetic baroreflex operating point was not changed 
during 100% oxygen administration, we observed a reduction in mean burst 
amplitude and total activity. This possibility, however, requires further investigation. 
Experimental Considerations 
This is the first study to record sympathetic neural discharges from Sherpa at 
HA. However, technically challenging conditions in Kathmandu limited the study to 
only four participants at a lower elevation. Furthermore, around half of Sherpa were 
light to moderate smokers and it is reported that tobacco smoking leads to increased 
basal MSNA and attenuates vascular sympathetic baroreflex sensitivity. However, 
smoking status was not a significant covariate for any indices in this study. 
Compared with Lowlanders, Sherpa were naive to the microneurographic technique, 
and may have experienced some anxiety during testing. Thus, we cannot rule out an 
overestimation of resting MSNA for Sherpa.  Ascent to 5050m was gradual, to 
facilitate acclimatization. However, it was not possible for groups of participants to 
arrive on separate days to minimize any confounding effects of the varying time 
course of acclimatization once at 5050m. While we acknowledge that a difference 
between day 10 and day 20 may have influenced our results, our analysis indicates 
that test day was not a significant covariate. We did not assess vascular sympathetic 
baroreflex gain to rising and falling pressure independently and we acknowledge that 
this fails to take baroreflex hysteresis into account (Rudas et al., 1999). A change in 
baseline MSNA may have influenced responsiveness of the vascular sympathetic 
baroreflex to both rising and falling pressures in an equal but opposite manner (Hart 
et al., 2011). 
The mechanisms by which sustained HA acclimatization produce baroreflex 
resetting and chronic sympathoexcitation require elucidation. Our findings suggest 
factors other than the peripheral chemoreflex play a role. We acknowledge that 
relative hypovolemia (Ryan et al., 2014), systemic inflammation and oxidative stress 
(Lewis et al., 2014), erythropoietin production (Oshima et al., 2018), and changes in 
intracranial pressure (Schmidt et al., 2018), all might influence sympathetic outflow in 
HA hypoxia. Furthermore, sympathetic activation in response to elevated pulmonary 
artery pressure has been shown in experimental animals (Moore et al., 2011). 
CONCLUSIONS 
We demonstrate highly effective arterial baroreflex control of sympathetic vasomotor 
activity in healthy humans during sustained hypoxia. Chronic resetting of the 
vascular sympathetic baroreflex supports elevated vasoconstrictor drive in 
Lowlanders during early acclimatisation to HA, but without an increase in resting 
arterial pressure. Sherpa, by comparison, have a lower vascular sympathetic 
baroreflex operating point and lower vasoconstrictor drive, but similar vascular 
resistance and arterial pressure. For Lowlanders, vascular sympathetic baroreflex 
resetting and heightened sympathetic activity may protect against orthostatic 
hypotension at high altitude. In contrast, Sherpa may have adapted to high altitude to 
require lower sympathetic outflow for homeostatic control of blood pressure. Such a 
difference may represent another example of a beneficial hypoxic adaptation in this 
highland population. 
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Authors Translational Perspectives 
Sustained activation of the sympathetic nervous system and reduced vascular 
sympathetic baroreflex responsiveness are features of several disease states 
involving chronic systemic hypoxemia. Together, chronic sympathetic nervous 
system activation and reduced vascular sympathetic baroreflex responsiveness 
facilitate elevated arterial pressure and hemodynamic instability in these populations. 
Our data demonstrate that sustained HA hypoxia, a model of chronic systemic 
hypoxemia independent of co-morbidity, is accompanied by sustained chronic 
sympathoexcitation. Notably, however, vascular sympathetic baroreflex 
responsiveness is preserved. Chronic resetting of vascular sympathetic baroreflex, 
and hence sympathoexcitation, at HA are important for blood pressure homeostasis 
in acclimatized lowlanders and well-adapted Sherpa. Furthermore, mechanisms 
acting independently of the peripheral chemoreflex appear to be involved in HA 
sympathoexcitation. This raises an intriguing possibility that these mechanisms could 
overlap with those that activate the sympathetic nervous system in disease states. 
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Figure 1. Example recordings of muscle sympathetic nerve activity (MSNA) and 
blood pressure (BP) from one representative Lowlander (aged 29 years) at A) Low 
altitude, B) during acute hypoxia, C) following 8 days at high altitude, D) during 100% 
oxygen breathing at high altitude and from one representative Sherpa (aged 26 
years) E) following 3 days at high altitude and F) during 100% oxygen breathing at 
high altitude. 
Figure 2. 
Figure 2. Vascular sympathetic baroreflex function: group average regressions 
between MSNA burst probability and DBP in Lowlanders (n=10) at 344m (LA) and 
5050m (HA) and in Sherpa at HA (n=7). The operating points are indicated by 
symbols and error bars (mean ± SD). MSNA operating point was significantly 
elevated in Lowlanders at HA, relative to Lowlanders at LA. MSNA operating point 
was lower in Sherpa relative to Lowlanders at HA, and similar to Lowlanders at LA. 
Operating DBP were similar. This indicated an upward resetting of the vascular 
sympathetic baroreflex following ascent to HA in Lowlanders. The slopes of the 
relationships were similar in Lowlanders at LA and HA (-2.3 ± 0.7 vs -2.6 ± 1.2; 
P=0.33) and similar in Sherpa at HA (-2.6 ± 0.9) compared to Lowlanders at both HA 
(P=0.98) and LA (P=0.99). This indicated no differences in vascular sympathetic 
baroreflex gain. 
Figure 3. 
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Figure 3. Cardiovagal baroreflex function: group average regressions between RRI 
and SBP in Lowlanders (n=10) at 344m (LA) and 5050m (HA) and in native Sherpa 
at HA (n=7). The operating points are indicated by symbols and error bars (mean ± 
SD). RRI significantly decreased in Lowlanders at HA, relative to Lowlanders at LA, 
but was similar in Sherpa relative to Lowlanders at HA. Operating SBP were similar. 
This indicated a downward (RRI) resetting of the cardiovagal baroreflex in 
Lowlanders following ascent to HA. The slope of the relationship, was less steep in 
Lowlanders at HA (16.2 ± 8.2) versus LA (20.6 ± 5.0; P=0.007), indicating a reduction 
in cardiovagal baroreflex gain following ascent to HA in Lowlanders. The slope of the 
relationship between SBP and RRI was similar in Sherpa at HA (12.9 ± 5.4; P=0.60) 
relative to Lowlanders at HA; indicating no differences in reflex gain. Compared to 
Lowlanders at LA, operating SBP was similar, but RRI was significantly smaller in 
Sherpa at HA, and the slope of the relationship was less steep (P=0.01) 
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Table 1. Doses of Sodium nitroprusside (SNP) and Phenylephrine (PE) administered 
in Lowlanders at 344m (LA) and 5050m (HA) and Sherpa at HA and the resultant 































SNP blood pressure decrease 
(mmHg) 
15 ± 6 15 ± 6 0.78 14 ± 4 0.9 
PE blood pressure increase 
(mmHg) 
19 ± 9 11 ± 3 0.02 15 ± 4 0.15 
Total blood pressure changes 
(mmHg) 
35 ± 11 26 ± 8 0.02 28 ± 6 0.15 
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Table 2. Haemodynamic and basal MSNA variables at 344m (LA), 1400m (KT) and 
5050m (HA). Data are presented as mean (± SD). ♦ Cardiac Output and Total 
Peripheral Resistance for Lowlanders, n = 10. Note: No intragroup comparison for 
Sherpa, HA versus KT, as only 3 were tested at both altitudes. 
Lowlanders Sherpa 









(n=14) P Value KT (n=4) 
HA 










81 ± 4 0.6 0.001 
Heart rate (bpm) 






73 ± 7 0.16 0.002 
Mean arterial 
pressure (mmHg) 



























































30 ± 13 0.02 0.16 
Mean burst 
amplitude (a.u) 
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Table 3. Manipulation of peripheral chemoreceptor drive in Lowlanders at 344m 
(LA). Data are presented as mean (± SD). ♦Cardiac Output and Total Peripheral 















SpO2 (%) 98 ± 1 84 ± 4 0.001 
Heart Rate (bpm) 53 ± 10 68 ± 15 0.001  56 ± 11 0.55 









♦ 0.002  5.7 ± 0.9 0.27 









♦ 0.01  15.9 ± 2.7 0.67 




) 11 ± 4 13 ± 6 0.43  11 ± 6 0.9 








0.06  549 ± 305 0.49 
Baroreflex Function 








0.02  -2.3 ± 0.9 0.35 
Diastolic operating pressure 
(mmHg) 
67 ± 7 70 ± 4 0.09  70 ± 9 0.14 




20 ± 6 19 ± 8 0.68  20 ± 9 0.77 








0.51 27.2 ± 17.4 0.24 
Systolic operating pressure 
(mmHg) 
117 ± 10 123 ± 7 0.12  121 ± 10 0.32 





0.001  1177 ± 245 0.78 
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Table 4. Manipulation of peripheral chemoreceptor drive in Lowlanders and Sherpa 

















SpO2 (%) 82 ± 4 97 ± 2 0.001 82 ± 5 99 ± 1 0.008 
Heart rate (bpm) 70 ± 12 61 ± 8 0.01 74 ± 6 62 ± 5 0.02 
Mean arterial pressure 
(mmHg) 

































30 ± 10 27 ± 11 0.35 22 ± 8 17 ± 6 0.14 
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